DHP Korea Co. Ltd (131030) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DHP Korea Co. Ltd (131030) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.29 Billion ≈ $3.59 Million USD) by net assets (₩150.47 Billion ≈ $101.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 131030 market cap for the company's overall valuation and market capitalisation.
DHP Korea Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how DHP Korea Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DHP Korea Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DHP Korea Co. Ltd ranked by their cash flow conversion efficiency. Explore DHP Korea Co. Ltd (131030) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hong Ho Precision Textile Co Ltd
TW:1446
|
0.002x |
|
iCRAFT Co. Ltd
KQ:052460
|
-0.202x |
|
BingEx Ltd
NASDAQ:FLX
|
0.126x |
|
Amarin Printing and Publishing Public Company Limited
BK:AMARIN
|
0.007x |
|
Fluoguide AS
ST:FLUO
|
4.485x |
|
Critical Elements Corporation
V:CRE
|
-0.036x |
|
Galway Metals Inc.
V:GWM
|
-0.119x |
|
Linc Limited
NSE:LINC
|
0.108x |
Annual Cash Flow Conversion Efficiency for DHP Korea Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of DHP Korea Co. Ltd from 2014 to 2024. View 131030 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩143.73 Billion ≈ $97.41 Million |
₩8.90 Billion ≈ $6.03 Million |
0.062x | -33.03% |
| 2023-12-31 | ₩134.45 Billion ≈ $91.12 Million |
₩12.44 Billion ≈ $8.43 Million |
0.093x | +462.97% |
| 2022-12-31 | ₩124.47 Billion ≈ $84.35 Million |
₩2.05 Billion ≈ $1.39 Million |
0.016x | -70.48% |
| 2021-12-31 | ₩127.02 Billion ≈ $86.08 Million |
₩7.07 Billion ≈ $4.79 Million |
0.056x | -62.06% |
| 2020-12-31 | ₩118.88 Billion ≈ $80.57 Million |
₩17.45 Billion ≈ $11.82 Million |
0.147x | -6.05% |
| 2019-12-31 | ₩107.75 Billion ≈ $73.02 Million |
₩16.83 Billion ≈ $11.41 Million |
0.156x | -1.48% |
| 2018-12-31 | ₩94.90 Billion ≈ $64.31 Million |
₩15.05 Billion ≈ $10.20 Million |
0.159x | -25.02% |
| 2017-12-31 | ₩86.55 Billion ≈ $58.66 Million |
₩18.30 Billion ≈ $12.40 Million |
0.211x | +32.18% |
| 2016-12-31 | ₩75.26 Billion ≈ $51.00 Million |
₩12.04 Billion ≈ $8.16 Million |
0.160x | -5.44% |
| 2015-12-31 | ₩65.49 Billion ≈ $44.38 Million |
₩11.08 Billion ≈ $7.51 Million |
0.169x | -25.43% |
| 2014-12-31 | ₩56.49 Billion ≈ $38.28 Million |
₩12.82 Billion ≈ $8.69 Million |
0.227x | -- |
About DHP Korea Co. Ltd
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more